Metoprolol Succinate Extended Release Tablets

Land: Neuseeland

Sprache: Englisch

Quelle: Medsafe (Medicines Safety Authority)

Wirkstoff:

Metoprolol succinate 23.75mg equivalent to metoprolol tartrate 25mg

Verfügbar ab:

AFT Pharmaceuticals Ltd

INN (Internationale Bezeichnung):

Metoprolol succinate 23.75 mg (equivalent to metoprolol tartrate 25mg)

Dosierung:

23.75 mg

Darreichungsform:

Modified release tablet

Zusammensetzung:

Active: Metoprolol succinate 23.75mg equivalent to metoprolol tartrate 25mg Excipient: Cellulose acetate Crospovidone Glyceryl monostearate Hypromellose Methacrylic acid copolymer Microcrystalline cellulose Opadry clear YS-1-7006 Opadry white YS-1-7003 Poloxamer 188 Polysorbate 80 Sugar spheres

Verschreibungstyp:

Prescription

Hergestellt von:

Watson Pharma Private Limited

Anwendungsgebiete:

Metoprolol Succinate Extended-Release Tablets are indicated for the treatment of: Hypertension - to lower blood pressure. Lowering blood pressure reduces the risk of fatal and non-fatal cardiovascular events, primarily strokes and myocardial infarctions.

Produktbesonderheiten:

Package - Contents - Shelf Life: Bottle, plastic, HDPE bottle with PP cap - 100 tablets - 36 months from date of manufacture stored at or below 25°C

Berechtigungsdatum:

2016-06-24